Journal
CIRCULATION
Volume 101, Issue 12, Pages 1459-1464Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.CIR.101.12.1459
Keywords
cardiomyopathy; enzymes; proteins; spectroscopy
Funding
- NHLBI NIH HHS [HL-07653, HL-56256, HL-49929] Funding Source: Medline
Ask authors/readers for more resources
Background - cAMP-dependent protein kinase (PKA) regulates a broad range of cellular responses in the cardiac myocyte. Downstream regulation of the PKA pathway is mediated by a class of scaffolding proteins called A-kinase anchoring proteins (AKAPs), which sequester PKA to specific subcellular locations through binding to its regulatory subunit (R). However, the effect of RU: autophosphorylation on AKAP binding and the degree of RII autophosphorylation in failing and nonfailing human hearts remains unknown. Methods and Results-We investigated AKAP-RII binding by overlay analysis and surface plasmon resonance spectroscopy and measured RII autophosphorylation in human hearts by backphosphorylation. Binding of Ht31 peptide (representing the RII-binding region of AKAPs) to cardiac RII was increased approximate to 145% (P<0.01) for autophosphorylated Ra: relative to unphosphorylated control. By surface plasmon resonance, RII autophosphorylation significantly increased binding affinity to Ht31 by approximate to 200% (P<0.01). Baseline PKA-dependent phosphorylation of RII was significantly decreased approximate to 30% (P<0.05) in human hearts with dilated cardiomyopathy compared with nonfailing controls. Conclusions-These results suggest that AKAP binding of PKA in the heart is regulated by RII autophosphorylation. Therefore AKAP targeting of PKA may be reduced; in patients with end-stage heart failure; This mechanism may be responsible for the decreased cAMP-dependent phosphorylation of proteins in dilated cardiomyopathy that we and others have previously observed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available